NORTHERN TRUST CORP - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$7,811,392
-2.2%
2,181,953
+0.8%
0.00%0.0%
Q2 2023$7,986,444
+30.7%
2,164,348
+17.2%
0.00%
+100.0%
Q1 2023$6,110,807
-4.8%
1,846,165
+11.6%
0.00%0.0%
Q4 2022$6,420,352
+66.8%
1,654,730
+4.4%
0.00%0.0%
Q3 2022$3,850,000
+21.3%
1,584,256
-1.2%
0.00%0.0%
Q2 2022$3,174,000
+375.9%
1,603,297
+340.2%
0.00%
Q1 2022$667,000
+29.3%
364,254
-0.3%
0.00%
Q4 2021$516,000
+62.8%
365,410
+30.3%
0.00%
Q3 2021$317,000
-33.1%
280,410
-5.3%
0.00%
Q2 2021$474,000
-66.0%
296,155
-62.7%
0.00%
Q1 2021$1,396,000
-15.9%
792,986
-6.7%
0.00%
Q4 2020$1,659,000
-16.9%
850,174
+1.8%
0.00%
Q3 2020$1,996,000
-19.1%
834,823
-0.9%
0.00%
-100.0%
Q2 2020$2,468,000
+0.2%
842,495
-1.5%
0.00%0.0%
Q1 2020$2,463,000
-5.1%
855,013
+31.8%
0.00%0.0%
Q4 2019$2,594,000
-8.4%
648,584
+1.9%
0.00%0.0%
Q3 2019$2,831,000
+144.5%
636,201
+112.6%
0.00%
Q2 2019$1,158,000
+16.9%
299,248
+14.4%
0.00%
Q1 2019$991,000
+76.0%
261,571
+11.1%
0.00%
Q4 2018$563,000
-61.6%
235,505
-0.2%
0.00%
Q3 2018$1,466,000
+55.3%
236,009
+12.8%
0.00%
Q2 2018$944,000
+604.5%
209,313
+618.2%
0.00%
Q1 2018$134,000
+32.7%
29,143
-7.2%
0.00%
Q4 2017$101,000
+206.1%
31,405
+197.5%
0.00%
Q3 2017$33,000
-15.4%
10,5550.0%0.00%
Q2 2017$39,000
-25.0%
10,5550.0%0.00%
Q1 2017$52,00010,5550.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital LLC 3,608,171$8,624,0002.44%
Broadfin Capital, LLC 4,226,077$10,100,0001.33%
MORGENS WATERFALL VINTIADIS & CO INC 400,000$956,0000.85%
Consonance Capital Management LP 4,588,352$10,966,0000.81%
Perceptive Advisors 6,521,102$14,542,0000.55%
Diag Capital Management, LP 182,100$435,0000.50%
683 Capital Management, LLC 805,000$1,924,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$120,0000.03%
AVANTAX ADVISORY SERVICES, INC. 65,050$156,0000.03%
PURA VIDA INVESTMENTS, LLC 37,170$89,0000.02%
View complete list of ADMA BIOLOGICS INC shareholders